Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine

The rapid growth of the global HIV/AIDS epidemic makes it a high priority to develop an effective vaccine. Since a live attenuated or inactivated HIV vaccine is not likely to be approved for clinical application due to safety concerns, HIV virus like particles (VLPs) offer an attractive alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, XiZhen, Wang, XiaoDan, Zhao, DongHai, Meng, XiangYu, Zhao, XingHong, Yu, XiangHui, Kong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press 2011
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089044/
https://www.ncbi.nlm.nih.gov/pubmed/22173311
http://dx.doi.org/10.1007/s11427-011-4244-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089044/
https://www.ncbi.nlm.nih.gov/pubmed/22173311
http://dx.doi.org/10.1007/s11427-011-4244-0

Ejemplares similares